Critical care for severe coronavirus disease 2019: a population-based study from a province with low case-fatality rate in China.

Author: Xue-Lian LIAO ¹ ; Hong CHEN ² ; Zhen LI ³ ; Bo WANG ¹ ; Zhong-Wei ZHANG ¹ ; Wei-Min LI ⁴ ; Zong-An LIANG ² ; Jin TANG ⁵ ; Jian WANG ⁵ ; Rui SHI ⁶ ; Xiao-Dong JIN ¹ ; Yan KANG ¹
Author Information

1. Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
2. Department of Critical Care Medicine, Public Health Clinical Centre of Chengdu, Chengdu, Sichuan 610066, China.
3. Clinical Research Centre, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China.
4. Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
5. Department of Critical Care Medicine, Guang'an People's Hospital, Guang'an, Sichuan 638001, China.
6. Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Collective Name:SUNRISE Group
Publication Type:Journal Article
MeSH: Adult; Aged; COVID-19/therapy*; China/epidemiology*; Critical Care; Female; Humans; Male; Middle Aged; SARS-CoV-2
From: Chinese Medical Journal 2020;134(1):98-100
CountryChina
Language:English